Role of genetics and sex steroid hormones in male androgenetic alopecia and female pattern hair loss: An update of what we now know

The role of genetic predisposition and the influence of sex steroid hormones are indisputable to the pathogenesis of male androgenetic alopecia (MAGA). The role of sex steroid hormones in female pattern hair loss (FPHL) is less known. A good knowledge of the pathophysiology underlying MAGA and FPHL empowers the clinician to confidently counsel patients and make informed therapeutic decisions. Vigorous research in recent years has provided greater insight into the role of genetics and sex steroids in physiological hair growth and cycling, as well as in hair follicle miniaturization, the histological hallmark of MAGA and FPHL. In the present review article directed towards clinicians, we discuss the current understanding of the role of androgens and oestrogens, as well as genetic associations with MAGA and FPHL. We also briefly discuss the interpretation of direct‐to‐consumer genetic testing for baldness to help clinicians understand the limitations of such tests.

[1]  D. Tobin,et al.  Plasticity and cytokinetic dynamics of the hair follicle mesenchyme: implications for hair growth control. , 2003, The Journal of investigative dermatology.

[2]  R. Sinclair.  Chronic telogen effluvium or early androgenetic alopecia? , 2004, International journal of dermatology.

[3]  Tobias Pincock.  Fitzpatrick's Dermatology in General Medicine , 2003 .

[4]  S. Harrap,et al.  The genetics of androgenetic alopecia. , 2001, Clinics in dermatology.

[5]  U. Blume-Peytavi,et al.  Effect of 5α-Dihydrotestosterone and Testosterone on Apoptosis in Human Dermal Papilla Cells , 2006, Skin Pharmacology and Physiology.

[6]  D. Altshuler,et al.  Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women. , 2007, Cancer research.

[7]  S. Cichon,et al.  The hairless gene in androgenetic alopecia: results of a systematic mutation screening and a family‐based association approach , 2002, The British journal of dermatology.

[8]  K. Kaufman.  Androgens and alopecia , 2002, Molecular and Cellular Endocrinology.

[9]  Thomas W. Mühleisen,et al.  Susceptibility variants for male-pattern baldness on chromosome 20p11 , 2008, Nature Genetics.

[10]  G. Giles,et al.  The E211 G>A Androgen Receptor Polymorphism Is Associated with a Decreased Risk of Metastatic Prostate Cancer and Androgenetic Alopecia , 2005, Cancer Epidemiology Biomarkers & Prevention.

[11]  D. Whiting.  Possible mechanisms of miniaturization during androgenetic alopecia or pattern hair loss. , 2001, Journal of the American Academy of Dermatology.

[12]  R. Sinclair,et al.  Quality of Life in Australian Women with Female Pattern Hair Loss~!2010-04-19~!2010-07-06~!2010-08-06~! , 2010 .

[13]  R. Smart,et al.  An estrogen receptor pathway regulates the telogen-anagen hair follicle transition and influences epidermal cell proliferation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[14]  S. Bernasconi,et al.  Decreased androgen receptor gene methylation in premature pubarche: a novel pathogenetic mechanism? , 2006, The Journal of clinical endocrinology and metabolism.

[15]  T. Spector,et al.  Male-pattern baldness susceptibility locus at 20p11 , 2008, Nature Genetics.

[16]  A. Petronis,et al.  Human morbid genetics revisited: relevance of epigenetics. , 2001, Trends in genetics : TIG.

[17]  C. Jahoda.  Cellular and developmental aspects of androgenetic alopecia , 1998, Experimental dermatology.

[18]  R. Sinclair,et al.  Men with Kennedy disease have a reduced risk of androgenetic alopecia , 2007, The British journal of dermatology.

[19]  O. Norwood,et al.  Female Androgenetic Alopecia: A Separate Entity , 2000, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[20]  R. Sinclair,et al.  The Ludwig pattern of androgenetic alopecia is due to a hierarchy of androgen sensitivity within follicular units that leads to selective miniaturization and a reduction in the number of terminal hairs per follicular unit , 2008, The British journal of dermatology.

[21]  J. Shapiro,et al.  Evaluation and treatment of male and female pattern hair loss. , 2005, Journal of the American Academy of Dermatology.

[22]  Andrew P Feinberg,et al.  An integrated epigenetic and genetic approach to common human disease. , 2004, Trends in genetics : TIG.

[23]  M. Sawaya,et al.  Different levels of 5alpha-reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia. , 1997, The Journal of investigative dermatology.

[24]  Poli Mara Spritzer,et al.  Association Between Androgen Receptor Gene CAG Repeat Polymorphism and Plasma Testosterone Levels in Postmenopausal Women , 2005, The Journal of the Society for Gynecologic Investigation: JSGI.

[25]  S. Davis,et al.  Minireview: Aromatase and the Regulation of Estrogen Biosynthesis-Some New Perspectives. , 2001, Endocrinology.

[26]  M. Nöthen,et al.  Genome-wide scan and fine-mapping linkage study of androgenetic alopecia reveals a locus on chromosome 3q26. , 2008, American journal of human genetics.

[27]  J. Hamilton.  Male hormone stimulation is prerequisite and an incitant in common baldness , 1942 .

[28]  E. Ludwig.  Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex , 1977, The British journal of dermatology.

[29]  J. Waldstreicher,et al.  Measuring reversal of hair miniaturization in androgenetic alopecia by follicular counts in horizontal sections of serial scalp biopsies: results of finasteride 1 mg treatment of men and postmenopausal women. , 1999, The journal of investigative dermatology. Symposium proceedings.

[30]  M. Frydman,et al.  Confirmation of the association between male pattern baldness and the androgen receptor gene. , 2005, European journal of dermatology : EJD.

[31]  S. Harrap,et al.  Baldness and the androgen receptor: the AR polyglycine repeat polymorphism does not confer susceptibility to androgenetic alopecia , 2007, Human Genetics.

[32]  R. Sinclair,et al.  Antiandrogen therapy for androgenetic alopecia , 2006 .

[33]  K. Lunetta.  Genetic Association Studies , 2008, Circulation.

[34]  N. Risch.  Searching for genetic determinants in the new millennium , 2000, Nature.

[35]  O. Norwood,et al.  Male Pattern Baldness: classification and Incidence , 1975, Southern medical journal.

[36]  O. Norwood.  Incidence of Female Androgenetic Alopecia (Female Pattern Alopecia) , 2001, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[37]  R Paus,et al.  The biology of hair follicles. , 1999, The New England journal of medicine.

[38]  G. Giles,et al.  Gene‐wide association study between the aromatase gene (CYP19A1) and female pattern hair loss , 2009, The British journal of dermatology.

[39]  S. Harrap,et al.  Polymorphism of the androgen receptor gene is associated with male pattern baldness. , 2001, The Journal of investigative dermatology.

[40]  E. Olsen.  Disorders of hair growth : diagnosis and treatment , 1994 .

[41]  Y. Lynfield.  Effect of pregnancy on the human hair cycle. , 1960, The Journal of investigative dermatology.

[42]  R. Happle,et al.  Influence of estrogens on the androgen metabolism in different subunits of human hair follicles. , 2001, European journal of dermatology : EJD.

[43]  S. Harrap,et al.  Evidence for two independent functional variants for androgenetic alopecia around the androgen receptor gene , 2010, Experimental dermatology.

[44]  J. Gustafsson,et al.  The hair follicle as an estrogen target and source. , 2006, Endocrine reviews.

[45]  V. Randall.  Androgens and human hair growth , 1994, Clinical endocrinology.

[46]  A. Fazekas,et al.  The metabolism of dehydroepiandrosterone by human scalp hair follicles. , 1973, The Journal of clinical endocrinology and metabolism.

[47]  A. Sharma,et al.  Female pattern hair loss. , 2012, Skinmed.

[48]  Paul R Burton,et al.  Key concepts in genetic epidemiology , 2005, The Lancet.

[49]  C. Perry,et al.  Letrozole: a review of its use in postmenopausal women with breast cancer. , 2004, Drugs.

[50]  A. Meikle.  5α-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia , 2008 .

[51]  J. Ellis.  Future Directions: Gene Polymorphism Diagnostics Relevant to Hair , 2010 .

[52]  Messenger,et al.  Diffuse female hair loss: are androgens necessary? , 1999, The British journal of dermatology.

[53]  S. White,et al.  Androgen Receptor Copy Number Variation and Androgenetic Alopecia: A Case-Control Study , 2009, PloS one.

[54]  N. Martin,et al.  Genetic basis of male pattern baldness. , 2003, The Journal of investigative dermatology.

[55]  B. Gilchrest,et al.  Biology of estrogens in skin: implications for skin aging , 2006, Experimental dermatology.

[56]  R. Happle,et al.  The inheritance of common baldness: two B or not two B? , 1984, Journal of the American Academy of Dermatology.

[57]  S. Andò,et al.  Adrenal androgens stimulate the proliferation of breast cancer cells as direct activators of estrogen receptor alpha. , 1999, Cancer research.

[58]  C. Hourseau,et al.  Hair cycle and alopecia. , 1994, Skin pharmacology : the official journal of the Skin Pharmacology Society.

[59]  S. Bulun.  Clinical review 78: Aromatase deficiency in women and men: would you have predicted the phenotypes? , 1996, The Journal of clinical endocrinology and metabolism.

[60]  G. Pons,et al.  Various Pharmacogenetic Aspects of Antiepileptic Drug Therapy , 2007, CNS drugs.

[61]  M. Hodgins,et al.  Distribution of androgen metabolizing enzymes in isolated tissues of human forehead and axillary skin. , 1978, The Journal of endocrinology.

[62]  D. Major,et al.  Failure to Show the Presence of a Chromaffin System of Cells in the Human Skin , 1960 .

[63]  J. Hamilton,et al.  Effect of castration in adolescent and young adult males upon further changes in the proportions of bare and hairy scalp. , 1960, The Journal of clinical endocrinology and metabolism.

[64]  S. Cichon,et al.  Genetic variation in the human androgen receptor gene is the major determinant of common early-onset androgenetic alopecia. , 2005, American journal of human genetics.

[65]  A. Shalita,et al.  Androgen Receptor Polymorphisms (CAG Repeat Lengths) in Androgenetic Alopecia, Hirsutism, and Acne , 1998, Journal of cutaneous medicine and surgery.

[66]  S. Inui,et al.  Role of androgen in mesenchymal epithelial interactions in human hair follicle. , 2005, The journal of investigative dermatology. Symposium proceedings.

[67]  J. Wilson,et al.  Regulation of human hair growth by steroid hormones. I. Testerone metabolism in isolated hairs. , 1974, The Journal of clinical endocrinology and metabolism.

[68]  M. Mahran,et al.  Evaluation of androgen receptor gene as a candidate gene in female androgenetic alopecia , 2009, International journal of dermatology.

[69]  J. Beckwith,et al.  Illusions of scientific legitimacy: misrepresented science in the direct-to-consumer genetic-testing marketplace. , 2010, Trends in genetics : TIG.

[70]  M. Kim,et al.  Dihydrotestosterone-inducible dickkopf 1 from balding dermal papilla cells causes apoptosis in follicular keratinocytes. , 2008, The Journal of investigative dermatology.

[71]  M. Philpott,et al.  Premature senescence of balding dermal papilla cells in vitro is associated with p16(INK4a) expression. , 2008, The Journal of investigative dermatology.

[72]  Andrea Picciau,et al.  EDA2R is associated with androgenetic alopecia. , 2008, The Journal of investigative dermatology.

[73]  R. Bergman,et al.  Androgenetic alopecia in heterozygous carriers of a mutation in the human hairless gene. , 2000, Journal of the American Academy of Dermatology.

[74]  A. Bird,et al.  Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals , 2003, Nature Genetics.

[75]  Lyons Mf.  The William Allan memorial award address: X-chromosome inactivation and the location and expression of X-linked genes. , 1988 .

[76]  R. Sinclair,et al.  Prevalence of male and female pattern hair loss in Maryborough. , 2005, The journal of investigative dermatology. Symposium proceedings.

[77]  J. Hamilton.  PATTERNED LOSS OF HAIR IN MAN: TYPES AND INCIDENCE , 1951, Annals of the New York Academy of Sciences.

[78]  Ralf Paus,et al.  Therapeutic strategies for treating hair loss , 2006 .

[79]  S. Yeh,et al.  From estrogen to androgen receptor: a new pathway for sex hormones in prostate. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[80]  Geoffrey B. Nilsen,et al.  Whole-Genome Patterns of Common DNA Variation in Three Human Populations , 2005, Science.

[81]  Terence Dwyer,et al.  American Journal of Epidemiology Review Prospects for Epigenetic Epidemiology , 2022 .

[82]  G. Keating,et al.  Valdecoxib , 2012, Drugs.

[83]  D. English,et al.  5α‐Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia , 2007, International journal of cancer.

[84]  V. Venning,et al.  Patterned androgenic alopecia in women. , 1988, Journal of the American Academy of Dermatology.